Affordability of Medicines, Public Health and TRIPS Regime: A Comparative Analysis
Keywords:
Price Regulation, Medicines, HealthcareAbstract
Price regulation in the pharmaceutical sector is an important instrument of public policy for promoting equity in access to health care. The kinds of drugs that would be left under price control are mostly irrelevant to public health. The issue of drugs has shifted from the realm of health to the realm of trade—a situation made worse by the rise of multinational pharmaceuticals that are trying to control and own knowledge in the name of intellectual property rights. In reality, the provisions under the Trade Related Intellectual Property Rights (TRIPS) agreement undermine some of the very processes that helped India become one of the leading countries in drug manufacturing with some of the lowest prices in the world.
References
1. NB Sarojini and others, note 73, p. 17.
2. Anita Kotwani . Prices & availability of common medicines at six sites in India using a standard methodology . Indian May 2007, p 646.
3. The Doha Declaration on the TRIPS Agreement and Public Health was adopted by the WTO Ministerial Conference of 2001 in Doha on November 14, 2001. It reaffirmed flexibility of TRIPS member states in circumventing patent rights for better access to essential medicines.
4. Philippe Cullet . Patents Bill, Trips and Right to Health . Economic and Political Weekly, vol. XXXV1/43, 27th October 2001, p. 4049.
5. http://www.who.int/medicines/areas/polic y/WHO_EDM_PAR_2002.3.pdf?ua=1
6. Available at: http://planningcommission.ni c.in/reports/genrep/bkpap2020/26_bg2020 .doc (accessed on 23/05/2019).
7. Ajit K Dalal , Subha Ray . Social Dimensions of Health. 23 (2005).
8. Mehta SR. Society and Health. 89 (1992).
9. Current Index of Medical Specialities. 2012;117 (2).
10. Karelia BN, Buch JG. Analysis of hematinic formulations available in the Indian market. J Pharmacol Pharmacother. 2012 Jan;3(1):35-8.
11. Available at: https://www.ncbi.nlm.nih.go v/pmc/articles/PMC4581141/ (accessed on 01/03/2019). IJHML (2019) 1-7 © Law Journals 2019. All Rights Reserved Page 7
12. Available at: https://nhsrcindia.org/.pdf_fil es/ (accessed on 04/04/2019).
13. Available at: https://www.wto.org/english/ tratop_e/dda_e/dohaexplained_e.htm (accessed on 22/05/2019).
14. Available at: https://www.who.int/medicin es/areas/policy/doha_declaration/en/ (accessed on 03/02/ 2019).
15. Article 15, International Covenant on Economic, Social and Cultural Rights.
16. Prachi Pallavi . Patents Regime and Right to Health . National and International Perspective.
17. Available at <http://www.legalservicesindi a.com/articles/pg.htm> (accessed on 04/12/2018).
18. Available at: https://www.wto.org/english/ thewto_e/minist_e/min01_e/mindecl_trips _e.doc (accessed on 22/05/2019).
19. Available from https://www.wto.org/englis h/thewto_e/minist_e/min01_e/mindecl_tri ps_e.htm (accessed on 08/05/2019).
20. Kumar R. Health and Human Development. 347 (2011).
21. Available at: https://ijme.in/articles/the- crisis-in-access-to-essential-medicines-in- india-key-issues-which-call-for- action/?galley=html (accessed on 08/05/2019). Cite this Article Bhupinder Singh . Affordability Of Medicines, Public Health and TRIPS Regime: A Comparative Analysis . Indian 2019; 2(1): 1–7p.
